We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current NAMS market cap is 2.01B. The company's latest EPS is EUR -1.9821 and P/E is -11.40.
| Quarter End | |
|---|---|
| EUR (€) | |
| Total Revenue | |
| Operating Income | |
| Net Income |
| Year End 31 December 2023 | 2023 |
|---|---|
| EUR (€) | |
| Total Revenue | 14.09M |
| Operating Income | -182.69M |
| Net Income | -176.94M |
| Quarter End | |
|---|---|
| EUR (€) | |
| Total Assets | |
| Total Liabilities | |
| Total Equity |
| Year End 31 December 2023 | 2023 |
|---|---|
| EUR (€) | |
| Total Assets | 347.1M |
| Total Liabilities | 58.7M |
| Total Equity | 288.39M |
| Market Cap | 2.01B |
| Price to Earnings Ratio | -11.40 |
| Price to Sales Ratio | 143.22 |
| Price to Cash Ratio | 5.93 |
| Price to Book Ratio | 7 |
| Dividend Yield | - |
| Shares Outstanding | 89.27M |
| Average Volume (1 week) | 131.23k |
| Average Volume (1 Month) | 218.47k |
| 52 Week Change | 56.30% |
| 52 Week High | 26.35 |
| 52 Week Low | 5.6326 |
| Spread (Intraday) | 13.84 (38.1%) |
| Company Name | NewAmsterdam Pharma Company NV |
| Address |
gooimeer 2-35 naarden, north holland 1411 DC |
| Website | https://www.newamsterdampharma.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
